All Access Articles |
- Alkermes Phase 3 Study Shows Significant Improvement in Idiopathic Hypersomnia | 2026-05-12 | PHARMACEUTICAL
- Alkermes CEO Richard Pops to Retire | 2026-02-25 | IRELAND
- Alkermes Appoints Joshua Reed as New CFO | 2025-09-12 | PHARMACEUTICAL